You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 1
  • P02.06 Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence

Article info

Article menu

Download PDFPDF

Poster Presentations
P02 Tumor microenvironment and microbiome in Immunotherapy
P02.06 Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence
Free

Authors

Citation

Dum D, Henke T, Mandelkow T, et al
P02.06 Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence
Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-ITOC8.18

Publication history

  • First published October 6, 2021.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.